Abingdon Health Statistics
Total Valuation
Abingdon Health has a market cap or net worth of GBP 31.42 million. The enterprise value is 28.66 million.
| Market Cap | 31.42M |
| Enterprise Value | 28.66M |
Important Dates
The last earnings date was Tuesday, March 17, 2026.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Abingdon Health has 433.39 million shares outstanding. The number of shares has increased by 17.21% in one year.
| Current Share Class | 251.08M |
| Shares Outstanding | 433.39M |
| Shares Change (YoY) | +17.21% |
| Shares Change (QoQ) | +4.31% |
| Owned by Insiders (%) | 6.39% |
| Owned by Institutions (%) | 46.66% |
| Float | 167.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.28 |
| PB Ratio | 4.99 |
| P/TBV Ratio | 8.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.84 |
| EV / Sales | 2.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.94 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.91 |
| Quick Ratio | 1.73 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -63.06 |
Financial Efficiency
Return on equity (ROE) is -50.98% and return on invested capital (ROIC) is -33.83%.
| Return on Equity (ROE) | -50.98% |
| Return on Assets (ROA) | -24.37% |
| Return on Invested Capital (ROIC) | -33.83% |
| Return on Capital Employed (ROCE) | -56.34% |
| Weighted Average Cost of Capital (WACC) | 5.62% |
| Revenue Per Employee | 74,202 |
| Profits Per Employee | -25,140 |
| Employee Count | 124 |
| Asset Turnover | 0.94 |
| Inventory Turnover | 10.37 |
Taxes
In the past 12 months, Abingdon Health has paid 82,000 in taxes.
| Income Tax | 82,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.23% in the last 52 weeks. The beta is 0.25, so Abingdon Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | +9.23% |
| 50-Day Moving Average | 6.69 |
| 200-Day Moving Average | 6.51 |
| Relative Strength Index (RSI) | 45.23 |
| Average Volume (20 Days) | 281,172 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Abingdon Health had revenue of GBP 9.57 million and -3.24 million in losses. Loss per share was -0.01.
| Revenue | 9.57M |
| Gross Profit | 3.96M |
| Operating Income | -3.97M |
| Pretax Income | -3.16M |
| Net Income | -3.24M |
| EBITDA | -3.42M |
| EBIT | -3.97M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.71 million in cash and 948,000 in debt, with a net cash position of 2.76 million or 0.01 per share.
| Cash & Cash Equivalents | 3.71M |
| Total Debt | 948,000 |
| Net Cash | 2.76M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 6.30M |
| Book Value Per Share | 0.01 |
| Working Capital | 3.20M |
Cash Flow
In the last 12 months, operating cash flow was -2.27 million and capital expenditures -346,000, giving a free cash flow of -2.62 million.
| Operating Cash Flow | -2.27M |
| Capital Expenditures | -346,000 |
| Depreciation & Amortization | 553,000 |
| Net Borrowing | -212,000 |
| Free Cash Flow | -2.62M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 41.38%, with operating and profit margins of -41.51% and -33.88%.
| Gross Margin | 41.38% |
| Operating Margin | -41.51% |
| Pretax Margin | -33.02% |
| Profit Margin | -33.88% |
| EBITDA Margin | -35.73% |
| EBIT Margin | -41.51% |
| FCF Margin | n/a |
Dividends & Yields
Abingdon Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.21% |
| Shareholder Yield | -17.21% |
| Earnings Yield | -10.32% |
| FCF Yield | -8.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Abingdon Health has an Altman Z-Score of -0.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.87 |
| Piotroski F-Score | 3 |